Portfolio

Open Innovation Platform and Portfolio

60° Pharmaceuticals, LLC (60P) has fully  embraced an open innovation platform to generate intellectual property and build our portfolio. We have active or are developing research collaborations with leading research institutions in the United States, Brazil, Singapore and Italy to discover and develop oral medications for dengue fever. Since our research and development activities are executed by our collaborators, we do not need centralized laboratory facilities. 

Portfolio

Website Builder